Financhill
Buy
74

XLY.TO Quote, Financials, Valuation and Earnings

Last price:
$0.1500
Seasonality move :
16.48%
Day range:
$0.1450 - $0.1500
52-week range:
$0.0250 - $0.1900
Dividend yield:
0%
P/E ratio:
4.92x
P/S ratio:
1.50x
P/B ratio:
1.17x
Volume:
571.7K
Avg. volume:
1.1M
1-year change:
400%
Market cap:
$202.3M
Revenue:
$122.3M
EPS (TTM):
$0.03

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
XLY.TO
Auxly Cannabis Group, Inc.
$35.9M -- 18.12% -- $0.2500
ACB.TO
Aurora Cannabis, Inc.
$86.5M -$0.03 4.79% -91.67% $7.80
CRON.TO
Cronos Group, Inc.
$51.3M -$0.07 33.92% -156.68% $3.95
OGI.TO
Organigram Global, Inc.
$73M -$0.01 71.72% -80% $3.40
TSND.TO
Terrascend Corp.
$92M -$0.03 -12.43% -74.49% $1.74
WEED.TO
Canopy Growth Corp.
$71.8M -$0.11 -5.09% -95.48% $3.76
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
XLY.TO
Auxly Cannabis Group, Inc.
$0.1500 $0.2500 $202.3M 4.92x $0.00 0% 1.50x
ACB.TO
Aurora Cannabis, Inc.
$6.37 $7.80 $360.4M 116.20x $0.00 0% 0.97x
CRON.TO
Cronos Group, Inc.
$3.75 $3.95 $1.4B 28.54x $0.00 0% 7.80x
OGI.TO
Organigram Global, Inc.
$2.64 $3.40 $355M 129.47x $0.00 0% 1.31x
TSND.TO
Terrascend Corp.
$1.00 $1.74 $305.5M -- $0.00 0% 0.77x
WEED.TO
Canopy Growth Corp.
$1.84 $3.76 $629.6M -- $0.00 0% 1.20x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
XLY.TO
Auxly Cannabis Group, Inc.
27.67% -1.082 33.75% 1.03x
ACB.TO
Aurora Cannabis, Inc.
15.87% 1.055 19.86% 1.52x
CRON.TO
Cronos Group, Inc.
0.16% 1.773 0.16% 20.73x
OGI.TO
Organigram Global, Inc.
2.45% 2.654 2.31% 1.21x
TSND.TO
Terrascend Corp.
73.06% 5.012 98.87% 0.71x
WEED.TO
Canopy Growth Corp.
26.05% 4.059 38.43% 4.06x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
XLY.TO
Auxly Cannabis Group, Inc.
$8.8M -$4.1M 22.71% 34.07% -10.27% $8.3M
ACB.TO
Aurora Cannabis, Inc.
-$8M -$56M -9.13% -10.69% -61.96% -$46.7M
CRON.TO
Cronos Group, Inc.
$24.8M -$6.9M 3.71% 3.71% -13.83% $12.4M
OGI.TO
Organigram Global, Inc.
$416K -$28M -6.89% -7.06% -35.03% -$554K
TSND.TO
Terrascend Corp.
$44.7M $15.3M -14.74% -38.6% 17.11% $620.3K
WEED.TO
Canopy Growth Corp.
$16.9M -$16.4M -39.84% -68.7% -24.59% -$19.4M

Auxly Cannabis Group, Inc. vs. Competitors

  • Which has Higher Returns XLY.TO or ACB.TO?

    Aurora Cannabis, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -58.83%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Aurora Cannabis, Inc.'s return on equity of -10.69%.

    Company Gross Margin Earnings Per Share Invested Capital
    XLY.TO
    Auxly Cannabis Group, Inc.
    22.15% $0.01 $238.5M
    ACB.TO
    Aurora Cannabis, Inc.
    -8.86% -$0.91 $667.4M
  • What do Analysts Say About XLY.TO or ACB.TO?

    Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Aurora Cannabis, Inc. has an analysts' consensus of $7.80 which suggests that it could grow by 20.56%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Aurora Cannabis, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Aurora Cannabis, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XLY.TO
    Auxly Cannabis Group, Inc.
    1 0 0
    ACB.TO
    Aurora Cannabis, Inc.
    2 2 0
  • Is XLY.TO or ACB.TO More Risky?

    Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Aurora Cannabis, Inc. has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.781%.

  • Which is a Better Dividend Stock XLY.TO or ACB.TO?

    Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Cannabis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Aurora Cannabis, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XLY.TO or ACB.TO?

    Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Aurora Cannabis, Inc. quarterly revenues of $90.4M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Aurora Cannabis, Inc.'s net income of -$53.2M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Aurora Cannabis, Inc.'s PE ratio is 116.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 0.97x for Aurora Cannabis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XLY.TO
    Auxly Cannabis Group, Inc.
    1.50x 4.92x $39.9M $20.5M
    ACB.TO
    Aurora Cannabis, Inc.
    0.97x 116.20x $90.4M -$53.2M
  • Which has Higher Returns XLY.TO or CRON.TO?

    Cronos Group, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of 77.94%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Cronos Group, Inc.'s return on equity of 3.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    XLY.TO
    Auxly Cannabis Group, Inc.
    22.15% $0.01 $238.5M
    CRON.TO
    Cronos Group, Inc.
    49.47% $0.09 $1.6B
  • What do Analysts Say About XLY.TO or CRON.TO?

    Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Cronos Group, Inc. has an analysts' consensus of $3.95 which suggests that it could grow by 5.33%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Cronos Group, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Cronos Group, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XLY.TO
    Auxly Cannabis Group, Inc.
    1 0 0
    CRON.TO
    Cronos Group, Inc.
    1 1 0
  • Is XLY.TO or CRON.TO More Risky?

    Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Cronos Group, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.958%.

  • Which is a Better Dividend Stock XLY.TO or CRON.TO?

    Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cronos Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Cronos Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XLY.TO or CRON.TO?

    Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Cronos Group, Inc. quarterly revenues of $50.1M. Auxly Cannabis Group, Inc.'s net income of $20.5M is lower than Cronos Group, Inc.'s net income of $39M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Cronos Group, Inc.'s PE ratio is 28.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 7.80x for Cronos Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XLY.TO
    Auxly Cannabis Group, Inc.
    1.50x 4.92x $39.9M $20.5M
    CRON.TO
    Cronos Group, Inc.
    7.80x 28.54x $50.1M $39M
  • Which has Higher Returns XLY.TO or OGI.TO?

    Organigram Global, Inc. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -47.42%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Organigram Global, Inc.'s return on equity of -7.06%.

    Company Gross Margin Earnings Per Share Invested Capital
    XLY.TO
    Auxly Cannabis Group, Inc.
    22.15% $0.01 $238.5M
    OGI.TO
    Organigram Global, Inc.
    0.52% -$0.28 $357.9M
  • What do Analysts Say About XLY.TO or OGI.TO?

    Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Organigram Global, Inc. has an analysts' consensus of $3.40 which suggests that it could grow by 28.79%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Organigram Global, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Organigram Global, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XLY.TO
    Auxly Cannabis Group, Inc.
    1 0 0
    OGI.TO
    Organigram Global, Inc.
    3 1 0
  • Is XLY.TO or OGI.TO More Risky?

    Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Organigram Global, Inc. has a beta of 2.213, suggesting its more volatile than the S&P 500 by 121.273%.

  • Which is a Better Dividend Stock XLY.TO or OGI.TO?

    Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Organigram Global, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Organigram Global, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XLY.TO or OGI.TO?

    Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Organigram Global, Inc. quarterly revenues of $80.1M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Organigram Global, Inc.'s net income of -$38M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Organigram Global, Inc.'s PE ratio is 129.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 1.31x for Organigram Global, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XLY.TO
    Auxly Cannabis Group, Inc.
    1.50x 4.92x $39.9M $20.5M
    OGI.TO
    Organigram Global, Inc.
    1.31x 129.47x $80.1M -$38M
  • Which has Higher Returns XLY.TO or TSND.TO?

    Terrascend Corp. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -15.22%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Terrascend Corp.'s return on equity of -38.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    XLY.TO
    Auxly Cannabis Group, Inc.
    22.15% $0.01 $238.5M
    TSND.TO
    Terrascend Corp.
    49.87% -$0.12 $487.1M
  • What do Analysts Say About XLY.TO or TSND.TO?

    Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Terrascend Corp. has an analysts' consensus of $1.74 which suggests that it could grow by 73.79%. Given that Terrascend Corp. has higher upside potential than Auxly Cannabis Group, Inc., analysts believe Terrascend Corp. is more attractive than Auxly Cannabis Group, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XLY.TO
    Auxly Cannabis Group, Inc.
    1 0 0
    TSND.TO
    Terrascend Corp.
    4 0 0
  • Is XLY.TO or TSND.TO More Risky?

    Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Terrascend Corp. has a beta of 1.913, suggesting its more volatile than the S&P 500 by 91.314%.

  • Which is a Better Dividend Stock XLY.TO or TSND.TO?

    Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Terrascend Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Terrascend Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XLY.TO or TSND.TO?

    Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Terrascend Corp. quarterly revenues of $89.7M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Terrascend Corp.'s net income of -$13.6M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Terrascend Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 0.77x for Terrascend Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XLY.TO
    Auxly Cannabis Group, Inc.
    1.50x 4.92x $39.9M $20.5M
    TSND.TO
    Terrascend Corp.
    0.77x -- $89.7M -$13.6M
  • Which has Higher Returns XLY.TO or WEED.TO?

    Canopy Growth Corp. has a net margin of 51.36% compared to Auxly Cannabis Group, Inc.'s net margin of -2.46%. Auxly Cannabis Group, Inc.'s return on equity of 34.07% beat Canopy Growth Corp.'s return on equity of -68.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    XLY.TO
    Auxly Cannabis Group, Inc.
    22.15% $0.01 $238.5M
    WEED.TO
    Canopy Growth Corp.
    25.3% -$0.01 $995.3M
  • What do Analysts Say About XLY.TO or WEED.TO?

    Auxly Cannabis Group, Inc. has a consensus price target of $0.2500, signalling upside risk potential of 66.67%. On the other hand Canopy Growth Corp. has an analysts' consensus of $3.76 which suggests that it could grow by 104.35%. Given that Canopy Growth Corp. has higher upside potential than Auxly Cannabis Group, Inc., analysts believe Canopy Growth Corp. is more attractive than Auxly Cannabis Group, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    XLY.TO
    Auxly Cannabis Group, Inc.
    1 0 0
    WEED.TO
    Canopy Growth Corp.
    1 4 1
  • Is XLY.TO or WEED.TO More Risky?

    Auxly Cannabis Group, Inc. has a beta of 1.254, which suggesting that the stock is 25.413% more volatile than S&P 500. In comparison Canopy Growth Corp. has a beta of 1.930, suggesting its more volatile than the S&P 500 by 92.97%.

  • Which is a Better Dividend Stock XLY.TO or WEED.TO?

    Auxly Cannabis Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canopy Growth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Auxly Cannabis Group, Inc. pays -- of its earnings as a dividend. Canopy Growth Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XLY.TO or WEED.TO?

    Auxly Cannabis Group, Inc. quarterly revenues are $39.9M, which are smaller than Canopy Growth Corp. quarterly revenues of $66.7M. Auxly Cannabis Group, Inc.'s net income of $20.5M is higher than Canopy Growth Corp.'s net income of -$1.6M. Notably, Auxly Cannabis Group, Inc.'s price-to-earnings ratio is 4.92x while Canopy Growth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Auxly Cannabis Group, Inc. is 1.50x versus 1.20x for Canopy Growth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XLY.TO
    Auxly Cannabis Group, Inc.
    1.50x 4.92x $39.9M $20.5M
    WEED.TO
    Canopy Growth Corp.
    1.20x -- $66.7M -$1.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.

Buy
54
UNF alert for Dec 23

UniFirst Corp. [UNF] is up 0.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock